BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

Free Newsletters
My Subscriptions

News by Subject
News by Disease
News by Date
Search News
Post Your News

Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Pharm Country
  Bio NC
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™


Company Profiles

Research Store

Research Events
Post an Event
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
 News By Date


 Monday, April 27, 2015
 Top Breaking News
 Featured Stories
 More News
Resverlogix Corporation (RVX.TO), Shenzhen Hepalink Pharma Strike Deal Worth $450 Million+
Teva (TEVA) Pays $23.2 Million to Dump OncoGenex Pharmaceuticals Inc. (OGXI) Drug
Synta (SNTA) CEO Steps Down, Replacement Named
TetraPhase Pharmaceuticals (TTPH)'s Eravacycline Meets Primary Endpoint In Phase III Study
NeoStem, Inc.'s Lead Immuno-Oncology Product Candidate, NBS20, Receives ATMP Classification From The European Medicines Agency
Bristol-Myers Squibb (BMY) Release: ALLY-1 Trial Results Show Investigational Daclatasvir-Based Regimen Cures 94% Of Post-Liver Transplant Patients With Hepatitis C And Up To 94% Of Hepatitis C Patients With Cirrhosis (Child-Pugh Class A Or B)
Enanta Pharmaceuticals, Inc. Announces Preliminary Data From AbbVie (ABBV)’s Phase 3b RUBY-I Study In Chronic Hepatitis C Patients With Renal Impairment Presented At The International Liver Congress 2015
Otonomy, Inc. (OTIC) Presents Auripro Phase III Results At American Society Of Pediatric Otolaryngology Conference
Gilead (GILD) Announces Results From Studies Evaluating Sofosbuvir-Based Regimens In Chronic Hepatitis C Patients With Genotypes 2-5
Celladon (CLDN) Reports Negative Results For CUPID2 Trial Of MYDICAR In Advanced Heart Failure
Achillion (ACHN) Presents Detailed Clinical Results On ACH-3102 And ACH-3422 At The International Liver Congress
Eli Lilly (LLY)'s CYRAMZA (ramucirumab) Receives Fourth FDA Approval
Pivotal Therapeutics Inc. Receives Health Canada Approval To Expand The Indication Of OMAZEN To Include Products With Claims To Maintain And Support Cardiovascular Health And Normal Triglyceride Levels
CureDuchenne Celebrates Submission Of First-Ever New Drug Application For Duchenne Muscular Dystrophy Amenable To Exon 51 Skipping; Cureduchenne Was Early Funder Of Drisapersen’s Development
BioMarin (BMRN) Completes Rolling NDA Submission To FDA For Drisapersen For Treatment Of Duchenne Muscular Dystrophy Amenable To Exon 51 Skipping
Merrimack (MACK) And Baxter BioScience Corporation (BAX) Announce Completion Of New Drug Application Submission To U.S. FDA For MM-398 As A Treatment For Post-Gemcitabine Metastatic Pancreatic Cancer
AbbVie (ABBV) Presents Late-Breaking, Preliminary Phase 3b Data with VIEKIRAX + EXVIERA In Chronic Hepatitis C Patients With Renal Impairment At The International Liver Congress 2015
Can-Fite BioPharma (CFBI) Reports Positive Results From Further Analysis Of Phase II/III Psoriasis Trial
RedHill Biopharma Ltd. (RDHL) Announces Completion Of Patient Enrollment In A Phase III Study Of RHB-105 For H. Pylori Infection
VentiRx Pharmaceuticals, Inc. Granted Orphan Drug Designation In The European Union For Motolimod In The Treatment Of Ovarian Cancer
aTyr Pharma Receives U.S. FDA Orphan Designation For Resolaris
Imperial Innovations Release: Autifony Therapeutics Recruits First Patient Into Phase IIa Trial For Age Related Hearing Loss
NeuroVive: FIrst Patient Enrolled In Clinical Phase II Study For Kidney Protection During Heart Surgery
Eiger Biopharma Announces Interim Results Of Lonafarnib In Combination With Ritonavir Or Pegylated Interferon In Patients Infected With Hepatitis Delta Virus (HDV)
ZIOPHARM, Inc. Announces Initiation of Phase 1b/2 Study of Ad-RTS-hIL-12 Gene Therapy in Patients With Locally Advanced or Metastatic Breast Cancer
Novira Therapeutics Announces Presentation Of Preclinical Antiviral Data For NVR 3-778 At EASL
Posters At ECCMID 2015 Highlight Preclinical Data From Synthetic Biologics' Novel SYN-005 Monoclonal Antibody Combination For The Treatment And Prophylaxis Of Whooping Cough (Pertussis)
Spring Bank Pharmaceuticals, Inc. Presents Preclinical And Clinical Data On Immunomodulatory Agent SB 9200 At The 2015 Annual Meeting Of The European Association For The Study Of The Liver
TAXIS Pharmaceuticals, Inc. Demonstrates Clinical Potential Of TXA709 In Combating Antibiotic Resistance
BioTime (BTX)’s Clinical Grade Stem Cells From Subsidiary ES Cell International To Be Used In Planned CIRM-Funded Preclinical Studies Of Huntington’s Disease
Tolero Pharmaceuticals Presents Data Demonstrating Profound Synergy Of Alvocidib And Bromodomain Protein Inhibitors In Nonclinical Models Of Acute Myeloid Leukemia
Theravance Biopharma Release: New Data Shows Greater In Vitro Potency For VIBATIV (Telavancin) Against Multidrug-Resistant Gram-Positive Bacteria, Including MRSA, Compared To Alternative Antibiotic Treatments
NanoViricides, Inc. (NNVC.PK) Discusses The Strong Effectiveness Of Its Anti-Herpes Drug Candidates In A Lethal Animal Model Of Dermal Herpes Infection
BioGaia: Positive Results In First Chinese Study With BioGaia’s Drops In Infants With Colic
Flex Pharma (FLKS) Initiates Human Proof-Of-Concept Efficacy Study In Nocturnal Leg Cramps
Stealth Biotherapeutics Expands Ocuvia’s Clinical Development Into Rare Mitochondrial Optic Neuropathies
Hospira Leadership Presents At Preeminent European Biosimilars Forum, Announces New White Paper On Extrapolation
University of Vienna Scientists Gain Unique Insight Into The Function Of A Key Muscle Protein
Late-Breaking Oral Presentation At The International Liver Congress (ILC 2015) Highlights RG-101's Potent, Durable And Pan-Genotypic Effects In Diverse HCV Population
Teva (TEVA) Reiterates Commitment To Cash-And-Stock Acquisition Of Mylan (MYL) For $82.00 Per Share
R-Tech Ueno: Announcement On Acquisition Of The Right To Develop And Commercialize DE-105 From Santen Pharmaceutical
Pernix (PTX) Closes Acquisition Of Zohydro ER Franchise
Karo Bio AB Closes Acquisition Of Product For Treatment Of Common Cold Through A Directed Issue
4D Molecular Therapeutics And Roche (RHHBY) Sign Collaboration Agreement For Gene Therapy Vector Discovery And Product Development
FEI Company Partners With George Washington University To Equip New Science & Engineering Hall
iBio, Inc. (IBIO) Arranges Production Of IBIO-CFB03 For Clinical Development With Caliber Biotherapeutics
Edico Genome, In Collaboration With Researchers From Harvard University And Stanford Universities, Speeds Analysis Of Whole Genome Sequence With 300x Depth Of Coverage Tenfold
Second Genome Announces Inflammatory Bowel Disease Research Alliance With The APC Microbiome Institute At University College Cork
Antares Pharma, Inc. (ATRS) Regains U.S. Marketing Rights To OTREXUP For Psoriasis Indication - Announces Termination Of LEO Pharma Marketing Agreement
Pfizer (PFE) And The Arthritis Society Team Up To Support Canadians With Arthritis
Cleveland Biolabs Inc. (CBLI) And Roswell Park Cancer Institute Announce Award Of Department Of Defense Breast Cancer Research Program Breakthrough Grant For Entolimod
MannKind Corporation (MNKD) To Manufacture 12 Unit Cartridge Strength Of AFREZZA Following FDA Approval
DS Healthcare Begins Shipping Its Hair Regrowth Tablets Integra On May 8th
Stempeutics Gets Stem Cell Patent In China (Chinese Application Number: CN201080053627) For Its Novel Stem Cell Drug 'Stempeucel'
GW Pharmaceuticals (GWPH) Announces Us Patent Allowance For Use Of Cannabidivarin (CBDV) In Treating Epilepsy
Forward Pharma (FWP) Receives Decision To Grant From EPO For DMF Patent In Europe
Molecular Health Gains Patent For Novel Receptor Utilizing Computational Biomarker Discovery Technology
Horizon Pharma (HZNP) Announces The U.S. Patent And Trademark Office Issuance Of An Additional Notice Of Allowance With Claims Covering Pennsaid 2%
Amarantus BioSciences, Inc. Closes $5 Million Preferred Stock Financing
CytoSorbents, Inc. Issues Letter To Shareholders
Pfenex (PFNX) Announces Pricing Of Follow-On Offering
INC Research, Inc. (INCR) Files Registration Statement For Secondary Offering
Coronado Biosciences (CNDO) Changes Its Name To Fortress Biotech
Akorn, Inc. (AKN) To Make Additional Financial Restatements
Sartorius Stedim Biotech Release: New Webinar On Faster cGMP Manufacturing Scale-up Of Biotherapeutics
Creative Bioarray Announces Short Tandem Repeat (STR) Analysis Service
Telesta Therapeutics Provides Key Corporate Updates
Astellas Pharma Inc. (ALPMY) Launches CRESEMBA (isavuconazonium sulfate) In The United States For The Treatment Of Invasive Aspergillosis And Invasive Mucormycosis
Smithers Viscient Supports Increasing Capacity Demands With Operation Expansions On East And West Coasts
Acucela Provides Important Company Updates
AxoGen, Inc. (AXGN) Announces 2015 Annual Shareholders’ Meeting
Arent Fox Wins For Luitpold At Second Circuit Court Of Appeals
TWi Pharmaceuticals, Inc. Announces Settlement With Takeda (TKPYY) On Dexilant(R) Litigation
Qu Biologics Opens Clinical Trial Sites In Edmonton And Toronto For Crohn's Disease Clinical Trial
University City Science Center Release: New Resident of Science Center’s Port Business Incubator Targets SARS And Ebola
PHT Corporation Selects Hewlett-Packard (HPQ) Elitepad 1000 With Windows 8.1 For Sitepad System In Eclinical Research
Pacific Biosciences (PACB) Introduces New Solutions For Comprehensive And Efficient Targeted Sequencing And Multiplexing Of Samples
Endo International (ENDP) To Announce First Quarter 2015 Financial Results On May 11, 2015
Enanta Pharmaceuticals, Inc. To Host Conference Call To Discuss Financial Results For The Fiscal Second Quarter And Six-Months Ended March 31, 2015
INSYS Therapeutics To Report First Quarter 2015 Results
IGI Laboratories, Inc. To Hold Conference Call For 1st Quarter 2015 Results
Jazz Pharmaceuticals (JAZZ) To Report 2015 First Quarter Financial Results On May 7, 2015
Medivation, Inc. (MDVN) Announces First Quarter 2015 Financial Results Teleconference On May 7, 2015
Mylan (MYL) Schedules First Quarter 2015 Financial Results Conference Call And Live Webcast
Nektar Therapeutics (NKTR) To Announce Financial Results For The First Quarter 2015 On Thursday, April 30, 2015, After Close Of U.S.-Based Financial Markets
Psychemedics Corporation (PMD) Announces First Quarter Earnings
REMINDER: West Pharmaceutical Services To Host First Quarter 2015 Conference Call
Invitae Appoints Robert Nussbaum, M.D., As Chief Medical Officer
Synta (SNTA) Announces Chen Schor Named President, Chief Executive Officer And Director
La Jolla Pharmaceutical Company (LJPC) Appoints Lakhmir S. Chawla, M.D., As Chief Medical Officer
Vic Myer, Ph.D. Joins Editas Medicine As Chief Technology Officer
BioScrip (BIOS) Appoints Veteran Finance Executive Jeffrey M. Kreger As Chief Financial Officer
Centene Corporation Expands Medical Team With Appointment Of Dr. Ken Yamaguchi As Chief Medical Officer
Amicus Therapeutics, Inc. (FOLD) Appoints David Allsop As Senior Vice President, International
Akorn, Inc. (AKN) Announces Recent Executive Appointments
Akorn, Inc. (AKN) Appoints Terry Rappuhn To Board Of Directors
aTyr Pharma Appoints Rare Disease Pioneer Mark Goldberg, M.D., To Board Of Directors
Celsion Corporation (CLSN) Announces Appointment Of Harriet Shelare To Director, Communications
Faheem Hasnain Joins Kura Oncology Board Of Directors
REPLICor Inc. Announces Four Appointments To Scientific Advisory Board
Scilex Pharmaceuticals Announces Commercial Executive Appointments
SynGen Inc. Expands Its Management Team
Novogen Limited (NVGN) Posts Details On Rights Issue Offering For Shareholders
Hi-Tech Responds To "Bullying Tactics" Issued By FDA On Acacia Rigidula
CDC Release: Expanding Naloxone Use Could Reduce Drug Overdose Deaths And Save Lives
China Cord Blood Corporation Announces Receipt Of "Going Private" Proposal
Aerocrine Responds To Recent Speculation In The Market
ESCMID Honours Médecins Sans Frontières With Special Excellence Award For Outstanding Achievements
Four Exceptional Contributions To The Advancement Of Clinical Microbiology And Infectious Diseases Recognized At ECCMID
Novartis Pharmaceuticals Corporation (NVS) Is First Company To Receive Number One Ranking Two Years In A Row On Diversityinc Top 50 Companies For Diversity List
PAREXEL International (PRXL) Honored With 2015 Clinical Innovator Of The Year Award From Partnerships In Clinical Trials
Agena Biosciences Names Bioyong Technology As Fifth Certified Service Provider In China
PRA Health Sciences Is Named International Clinical Company Of The Year
Vital Therapies, Inc. (VTI) (VTL) Announces Poster Presentations From The Annual Meeting Of The European Association For The Study Of The Liver And Upcoming First Quarter Financial Results Conference Call With Webcast
Evogene Ltd. (EVGN) CEOOfer Haviv And Marrone Bio Innovations, Inc CEO Pam Marrone To Participate In 'Profiling Tomorrow's Ag Solutions' Panel Discussion At Agrivest 2015
Dr. Robert Hanzlik Discusses Pharmaceutical Testing Models At Event Hosted By National University
Applied Genetic Technologies Corporation Announces Participation In Upcoming Conferences
Geron Corporation (GERN) To Present At The Bank of America (BAC) Merrill Lynch Healthcare Conference
StemCells (STEM) To Participate At The Inaugural World Medical Innovation Forum
Alcobra (ADHD) To Participate At Two Conferences In May
Aquinox Pharmaceuticals (AQXP) To Present At 2015 Bloom Burton & Co. Healthcare Investor Conference
Sobi Release: Statement Regarding Recent Speculation
Cellular Biomedicine Group (CBMG) To Present Cancer CAR-T CD30 Therapy Clinical Development Program At The 10th Annual World Stem Cells & Regenerative Medicine Congress In London, UK
Aratana Therapeutics (PETX) Comments On ADXS31-164 (AT-014) Study Data Presented During Poster Session At The AACR Annual Meeting 2015
MedDay To Webcast Results Of Its Pivotal Phase III Study Of MD1003 In Patients With Progressive Multiple Sclerosis
Provectus Biopharmaceuticals Inc. To Present At Asia Biotech Invest 2015 Conference Wednesday, May 20, 2015, Hong Kong
RXi Pharmaceuticals (RXII) Announces Upcoming Presentations At Leading Partnering And Scientific Conferences
Roka Bioscience, Inc. (ROKA) To Exhibit And Present At The 2015 Food Safety Summit
m2p-labs Presents New Video Of Biolector Pro System At SBFC
Experts In Pharma, Clinical Research, Omics, Environmental And Food Testing Meet For SCIEX’s 6th LC-MS/MS Symposium In Berlin
Heron Therapeutics, Inc. (APPA) To Present At The Bank of America (BAC) Merrill Lynch 2015 Health Care Conference
Cerus Corporation (CERS) To Present At AABB Symposium On Pathogen-Reduced Components
For Big Pharma In China, Innovation Is In The Eye Of The Beholder
Week In Review: Haohai Biological Schedules $305 Million Hong Kong IPO